Reid Bengard
Reid started conducting market research for biotechnology and pharmaceutical companies in 1997. His experience spans qualitative and quantitative studies across dozens of therapeutic categories, including actinic keratosis, anemia, bone fracture, breast cancer, CRC, diabetes, NSCLC, hemophilia, lymphomas, multiple myeloma, MS, neutropenia, prostate cancer, pain, psoriasis, and RA, among others. Prior to starting Aquest, Reid held senior positions at ZS Associates and Ziment. Reid has a BS from the University of California at Davis and an MBA from the Wharton School of the University of Pennsylvania.